Skip to main content
HR 5347 108th Congress House Crime and Law Enforcement Administrative remedies Commerce Department of Justice Drug abuse Drug law enforcement Drug traffic Drugs Federal preemption Government Operations and Politics Health Judicial review Law Local laws Methamphetamine Packaging Retail trade State laws

Methamphetamine Abuse Prevention Act of 2004

Introduced: October 8, 2004 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 5, 2004
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Oct 8, 2004
Referred to the Subcommittee on Health.
Oct 8, 2004
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 8, 2004
Introduced in House
 Plain-English summary Congressional Research Service

Methamphetamine Abuse Prevention Act of 2004 - Amends the Controlled Substances Act to: (1) reduce the retail sales threshold for the sale of products containing pseudoephedrine or phenylpropanolamine products from nine grams to six grams; and (2) eliminate the "regulated transaction" exemption for any over-the-counter sale of such products (including blister packs) by retail distributors.

Prohibits any State, political subdivision, or State authorized entity from establishing any requirement for retail sales of any pseudoephedrine drug product that is different from the requirements that apply to such products under this Act. Makes this provision inapplicable to any requirement enacted prior to January 1, 2005, other than a requirement allowing any individual to purchase more than six grams of pseudoephedrine base in any single retail transaction. Allows the State to adopt penalties that are different from penalties that apply under this Act.

Authorizes exemptions from this prohibition upon a determination by the Attorney General that pseudoephedrine drug products obtained in the State are being used as a significant source of precursor chemicals for illegal manufacture of a controlled substance for distribution or sale, that the requirement is likely to substantially decrease such use, and that the requirement will not unduly burden interstate commerce. Sets forth provisions governing judicial review.

What's happening now November 5, 2004

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Republican 1